Altimmune (ALT) Return on Invested Capital (QoQ) (2013 - 2025)

Altimmune (ALT) Return on Invested Capital (QoQ) (2013 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,132.22 Bn 67,131.94 Bn -
2 Nanobiotix 1,910.87 Bn 1,910.81 Bn -
3 Akari Therapeutics 989.71 Bn 989.71 Bn -
4 BeOne Medicines 471.60 Bn 466.80 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.71 Bn 114.46 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.83 Bn 61.07 Bn 3.31 Bn
7 Belite Bio 62.74 Bn 62.74 Bn -
8 Argenx Se 55.83 Bn 50.65 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.33 Bn 34.32 Bn 959.66 Mn
10 Altimmune 368.41 Mn 368.41 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 13.00
Dec 31, 2022 -3.00
Mar 31, 2016 -9.00
Dec 31, 2015 0.00
Sep 30, 2015 1.00
Jun 30, 2015 -1.00
Mar 31, 2015 1.00
Dec 31, 2014 0.00
Sep 30, 2014 -1.00
Jun 30, 2014 0.00
Mar 31, 2014 0.00
Dec 31, 2013 -1.00
Sep 30, 2013 0.00
Jun 30, 2013 0.00
Mar 31, 2013 1.00